Ketamine and its metabolite, (2R,6R)-HNK, restore hippocampal LTP and long-term spatial memory in the Wistar-Kyoto rat model of depression

被引:0
|
作者
Lily R. Aleksandrova
Yu Tian Wang
Anthony G. Phillips
机构
[1] Djavad Mowafaghian Centre for Brain Health,Department of Psychiatry
[2] University of British Columbia,Department of Medicine
[3] University of British Columbia,undefined
[4] University of British Columbia,undefined
来源
关键词
Ketamine; Synaptic plasticity; LTP; Hippocampus; HNK; Antidepressant; Memory and cognition; Wistar-Kyoto rat; Model of depression;
D O I
暂无
中图分类号
学科分类号
摘要
Accumulating evidence implicates dysregulation of hippocampal synaptic plasticity in the pathophysiology of depression. However, the effects of ketamine on synaptic plasticity and their contribution to its mechanism of action as an antidepressant, are still unclear. We investigated ketamine’s effects on in vivo dorsal hippocampal (dHPC) synaptic plasticity and their role in mediating aspects of antidepressant activity in the Wistar-Kyoto (WKY) model of depression. dHPC long-term potentiation (LTP) was significantly impaired in WKY rats compared to Wistar controls. Importantly, a single low dose (5 mg/kg, ip) of ketamine or its metabolite, (2R,6R)-HNK, rescued the LTP deficit in WKY rats at 3.5 h but not 30 min following injection, with residual effects at 24 h, indicating a delayed, sustained facilitatory effect on dHPC synaptic plasticity. Consistent with the observed dHPC LTP deficit, WKY rats exhibited impaired hippocampal-dependent long-term spatial memory as measured by the novel object location recognition test (NOLRT), which was effectively restored by pre-treatment with both ketamine or (2R,6R)-HNK. In contrast, in WKYs, which display abnormal stress coping, ketamine, but not (2R,6R)-HNK, had rapid and sustained effects in the forced swim test (FST), a commonly used preclinical screen for antidepressant-like activity. The differential effects of (2R,6R)-HNK observed here reveal a dissociation between drug effects on FST immobility and dHPC synaptic plasticity. Therefore, in the WKY rat model, restoring dHPC LTP was not correlated with ketamine’s effects in FST, but importantly, may have contributed to the reversal of hippocampal-dependent cognitive deficits, which are critical features of clinical depression. Our findings support the theory that ketamine may reverse the stress-induced loss of connectivity in key neural circuits by engaging synaptic plasticity processes to “reset the system”.
引用
收藏
相关论文
共 16 条
  • [1] Ketamine and its metabolite, (2R,6R)-HNK, restore hippocampal LTP and long-term spatial memory in the Wistar-Kyoto rat model of depression
    Aleksandrova, Lily R.
    Wang, Yu Tian
    Phillips, Anthony G.
    MOLECULAR BRAIN, 2020, 13 (01)
  • [2] Analgesic and Antinociceptive Effects of the Ketamine Metabolite (2R,6R)-Hydroxynorketamine (HNK) in Mice
    Yost, Jonathan
    Browne, Caroline
    Lucki, Irwin
    NEUROPSYCHOPHARMACOLOGY, 2021, 46 (SUPPL 1) : 271 - 271
  • [3] Theories on the Mechanism of Action of Ketamine: From NMDA Receptor Inhibition to the (2R, 6R)-HNK Metabolite
    Zarate, Carlos
    Gould, Todd
    Zanos, Panos
    Machado-Vieira, Rodrigo
    BIOLOGICAL PSYCHIATRY, 2017, 81 (10) : S33 - S34
  • [4] Ketamine Metabolite (2R,6R)-Hydroxynorketamine Induces Sustained Metaplastic Effects on Hippocampal Synaptic Plasticity in Mice
    Brown, Kyle
    Gould, Todd
    NEUROPSYCHOPHARMACOLOGY, 2023, 48 : 270 - 271
  • [5] Rapid Hippocampal Synaptic Potentiation Induced by Ketamine Metabolite (2R,6R)-Hydroxynorketamine Persistently Primes Synaptic Plasticity
    Brown, Kyle
    Gould, Todd
    NEUROPSYCHOPHARMACOLOGY, 2024, 49 : 205 - 206
  • [6] The ketamine metabolite (2R,6R)-hydroxynorketamine rescues hippocampal mRNA translation, synaptic plasticity and memory in mouse models of Alzheimer's disease
    Ribeiro, Felipe C.
    Cozachenco, Danielle
    Argyrousi, Elentina K.
    Staniszewski, Agnieszka
    Wiebe, Shane
    Calixtro, Joao D.
    Soares-Neto, Rubens
    Al-Chami, Aycheh
    El Sayegh, Fatema
    Bermudez, Sara
    Arsenault, Emily
    Cossenza, Marcelo
    Lacaille, Jean-Claude
    Nader, Karim
    Sun, Hongyu
    De Felice, Fernanda G.
    Lourenco, Mychael V.
    Arancio, Ottavio
    Aguilar-Valles, Argel
    Sonenberg, Nahum
    Ferreira, Sergio T.
    ALZHEIMERS & DEMENTIA, 2024, 20 (08) : 5398 - 5410
  • [7] Rapid hippocampal synaptic potentiation induced by ketamine metabolite (2R,6R)-hydroxynorketamine persistently primes synaptic plasticity
    Brown, Kyle A.
    Ajibola, Musa I.
    Gould, Todd D.
    NEUROPSYCHOPHARMACOLOGY, 2025, : 928 - 940
  • [8] Lack of Antidepressant Effects of (2R,6R)-Hydroxynorketamine in a Rat Learned Helplessness Model: Comparison with (R)-Ketamine
    Shirayama, Yukihiko
    Hashimoto, Kenji
    INTERNATIONAL JOURNAL OF NEUROPSYCHOPHARMACOLOGY, 2018, 21 (01): : 84 - 88
  • [9] (R)-Ketamine Shows Greater Potency and Longer Lasting Antidepressant Effects Than Its Metabolite (2R,6R)-Hydroxynorketamine
    Yang, Chun
    Qu, Youge
    Abe, Masahito
    Nozawa, Dai
    Chaki, Shigeyuki
    Hashimoto, Kenji
    BIOLOGICAL PSYCHIATRY, 2017, 82 (05) : E43 - E44
  • [10] A Pharmacological Evaluation of the Analgesic Effect and Hippocampal Protein Modulation of the Ketamine Metabolite (2R,6R)-Hydroxynorketamine in Murine Pain Models
    Das, Vaskar
    Basovich, Michael B.
    Thomas, Craig J.
    Kroin, Jeffrey S.
    Buvanendran, Asokumar
    Mccarthy, Robert J.
    ANESTHESIA AND ANALGESIA, 2024, 138 (05): : 1094 - 1106